BRCA Positive? UK Insurers Cannot Ask for That

If you have a BRCA1 or BRCA2 result and a life insurance application open in front of you, here is the short version: a UK insurer cannot ask you for that result, and you do not have to volunteer it. A positive predictive BRCA result is one of the pieces of information that is deliberately kept off the application. So the honest answer to BRCA life insurance worries is that the gene test itself is not the obstacle a lot of American articles make it sound.

That is the part people get wrong, because most of what turns up in a search was written for a country with different rules. But BRCA is not a single question with a single answer. It is really four situations wearing the same name, and only one of them — the raw predictive result — is fully protected. A cancer diagnosis, risk-reducing surgery and a negative test each sit in a different place. Getting them straight is the difference between an application that goes smoothly and one that comes unstuck at claim.

This page separates the four, tells you which must be disclosed if the insurer asks, and shows you where the protection comes from so you are not relying on our word for it.

The four situations hiding inside one question

People type "do I have to declare BRCA to an insurer UK" as if BRCA were one fact. It is not. The word covers a predictive test taken while you are well, a diagnosis if cancer has actually developed, any preventative surgery you chose to have, and the specific case of testing negative in a family that carries a known fault. The rules treat these very differently, and the reason online advice feels contradictory is that different articles are silently answering different ones.

So take them one at a time. Only the first — the predictive result on its own — is the thing insurers are barred from touching. The other three are ordinary parts of a medical application, and pretending otherwise is how a genuine claim later gets questioned.

Part one: the predictive result they cannot ask for

A predictive genetic test is one taken before any illness, to see whether you carry a fault that raises your future risk. A BRCA1 or BRCA2 test done because the fault runs in your family, while you are perfectly well, is exactly that.

In the UK, that result is protected by an agreement between the government and the insurance industry, the Code on Genetic Testing and Insurance. Its central commitment is straightforward, and it is worth reading rather than paraphrasing:

Insurers will not ask an applicant to take a predictive genetic test, and will not require or use the result of one when deciding whether to offer cover or on what terms — with a single listed exception, described below.

That exception is Huntington's disease, and it applies only to life insurance where the total cover applied for is more than £500,000. Nothing else is on the approved list. BRCA1 and BRCA2 are not, at any level of cover. So a predictive BRCA result cannot lawfully shape your life insurance decision under the Code, and the insurer is not permitted to ask for it in the first place.

Source: HM Government and the Association of British Insurers, Code on Genetic Testing and Insurance.

This is also why the American answer misleads. In the United States, federal law restricts the use of genetic information in health insurance and employment but not in life insurance, and several states allow life insurers to use predictive results. Advice built on that framework tells you to rush cover into place before you test. In the UK the protection is already there, which changes the whole calculation. We set out that difference in full in our look at whether you should buy cover before genetic testing, which is usually not necessary here.

Part two: a diagnosis is a different question entirely

Protection for the gene result does not extend to cancer itself. If a BRCA fault has already led to a diagnosis — breast, ovarian, prostate, pancreatic or another associated cancer — that diagnosis is ordinary medical history. It has nothing to do with the genetics rules. An insurer is fully entitled to ask about diagnoses, investigations and treatment, and you must answer those questions.

The distinction the Code draws is between a predictive test, taken while well, and a diagnostic one, taken to confirm what is already suspected because of symptoms or findings. A diagnostic genetic test is treated like any other piece of medical evidence, because by then it is describing an illness you have, not a risk you carry.

If you have had cancer and been treated, underwriting depends heavily on the type, the stage, how long ago it was and how you have been since. Time matters, and being through treatment is not the same in an underwriter's eyes as being years clear. We have written separately about why the phrase a family history question, answered wrongly, can affect whether a policy pays, and about how honestly answering the medical questions protects the people who will one day claim.

Part three: risk-reducing surgery is medical history, not a gene result

Many people who test BRCA-positive choose risk-reducing surgery — most commonly a preventative mastectomy, or removal of the ovaries and fallopian tubes — precisely because they are well and want to stay that way. This is one of the most misunderstood corners of the whole subject.

The surgery is an operation, and operations are disclosable. If the application asks about surgery, hospital admissions or procedures, a risk-reducing mastectomy must be declared. That is true even though the gene result that prompted it cannot be asked for. You disclose the fact of the operation and answer factually about it; you are not required to hand over the predictive test result that sat behind the decision.

In practice an underwriter who sees preventative surgery will usually want to understand the reason, and that conversation can circle close to the genetics. The line to hold is the one the Code draws: the surgery and your medical facts are fair questions; the predictive result itself is not. People searching "life insurance after preventative mastectomy UK" are often afraid that mentioning the operation drags the whole gene story onto the form. It does not have to, and a broker who knows this area can help you answer accurately without over-disclosing.

Part four: a negative result you are allowed to share

The fourth situation runs the opposite way. Suppose your family carries a known BRCA fault, but you were tested and do not carry it. Your family history alone might make an insurer cautious. A negative test for the family's specific fault is strong evidence that the particular risk does not apply to you.

The Code works as a one-way ratchet here. An unfavourable predictive result cannot be asked for or used against you. But a favourable one — a negative test that rules out a risk your family history would otherwise suggest — is something you are allowed to volunteer, and insurers are able to take it into account. You are never obliged to, and it only carries real weight where the family's fault is known and you were tested for that exact fault. We cover this in detail in our piece on why, having tested BRCA-negative in a BRCA family, it can be worth saying so.

Critical illness and income protection are covered too

The BRCA answer for life cover carries across to critical illness cover and income protection, which the Code also covers, each with its own separate financial limit. As things stand, no genetic test at all is approved for use with critical illness or income protection — not even Huntington's — so a predictive BRCA result cannot be asked for on those products either.

What insurers can still do, on every product, is ask about your family history in general terms and about your own diagnoses, tests and treatment. A question such as "has a parent or sibling had cancer before a certain age" is a family-history question, not a genetics one, and it is a legitimate thing to be asked. The protected item is specifically the predictive test result, not the existence of illness in your family.

Because BRCA sits alongside preventative surgery and, sometimes, ongoing surveillance, it is worth getting quotes through someone who understands how the pieces fit rather than guessing on a comparison site. You can get life insurance quotes and have an FCA-authorised broker approach it in the right order — level term cover is the usual shape for family protection — so the medical questions are answered accurately and the gene result stays where the Code puts it.

What "reasonable care" actually asks of you

Underneath all of this is the Consumer Insurance (Disclosure and Representations) Act 2012, which governs what you have to tell an insurer. It does not demand that you volunteer everything you can think of. It asks you to take reasonable care not to make a misrepresentation — in plain terms, to answer the questions you are actually asked honestly and carefully.

Read against BRCA, that means three things. You answer medical questions — diagnoses, surgery, investigations — fully and accurately. You are not required to offer up a predictive result the insurer is not allowed to ask for. And if you choose to volunteer a favourable negative result, that is your option, not an obligation. Get this framework right and there is nothing about a BRCA result that should trouble a future claim; get it wrong on the medical facts and a claim can be challenged. If cover is postponed while something is looked into, that is a delay rather than a refusal — we explain why a postponement for twelve months is not the same as a decline.

If you ever suspect a genetic result influenced a decision when it should not have, there is a defined route to challenge it, which we map in our guide to challenging a genetics decision and the deadlines that apply. And for the wider picture of how family history and the odds actually work, the family history, inherited risk and the odds hub pulls the threads together.

Scotland and Northern Ireland

The Code on Genetic Testing and Insurance is an agreement covering insurers operating across the United Kingdom, so the core position — a predictive BRCA result cannot be asked for or used, Huntington's above £500,000 aside — is the same in Scotland and Northern Ireland as in England and Wales. So is the Consumer Insurance (Disclosure and Representations) Act 2012, which applies UK-wide.

What can differ between the nations is the clinical pathway around you: how NHS genetics services are organised, referral thresholds for testing, and the surveillance offered to people with a known fault. Those affect your medical history and screening, not the insurance rule itself. If your situation started with a sudden loss rather than a planned test, our piece on what happens when a brother dies suddenly and the family is offered screening covers that route, and for the plain arithmetic underneath every risk conversation, your real chance of dying before 65 is a steadier place to start than a headline about a gene.

Frequently asked questions

Can a UK insurer ask if I have tested positive for BRCA?

No. A predictive BRCA1 or BRCA2 result cannot be requested or used for life insurance under the Code on Genetic Testing and Insurance. Only Huntington's disease appears on the list of results that may ever be asked about, and only above £500,000 of life cover. BRCA is not on that list at any level, so you need not declare a predictive result.

What about a risk-reducing mastectomy?

Surgery is medical history, not a gene result. If you are asked about operations, hospital admissions or treatment, risk-reducing surgery must be disclosed, and it may prompt questions about why it was done. Answer factually about the surgery itself; the predictive test result behind it remains outside what an insurer is allowed to require.

Does a BRCA result affect critical illness cover too?

The Code covers critical illness and income protection as well as life cover, each with its own financial limit, and no genetic test is currently approved for use with those products. So a predictive BRCA result cannot be asked for there either. Insurers may still ask about your family history in general and about your own diagnoses, tests and treatment.